11 / 7 / 2017 2.38pm
Responding to the commitment by secretaries of state Jeremy Hunt and Greg Clark to seek a collaborative relationship with the EU in trade, medicines regulation and supply, Niall Dickson, co chair of the Brexit Health Alliance, said:
“This is a really important and welcome signal. If we get these negotiations wrong, there is a real danger that patients could be denied access to cutting edge treatments, and indeed access to a wide range of innovative health technologies. The determination of the UK government to continue with a regulatory system that protects and supports the life science sector is very welcome.
“The current EU medicines research, development and regulatory arrangements work well and benefit from the input of UK academics, regulators and industry. For patients in the UK and across Europe we must maintain the highest possible level of collaboration and regulatory alignment.”